Works matching IS 00223417 AND DT 2014 AND VI 232 AND IP 2
Results: 19
The genetic complexity of common cancers and the promise of personalized medicine: is there any hope?
- Published in:
- Journal of Pathology, 2014, v. 232, n. 2, p. 274, doi. 10.1002/path.4276
- By:
- Publication type:
- Article
Towards the introduction of the 'Immunoscore' in the classification of malignant tumours.
- Published in:
- Journal of Pathology, 2014, v. 232, n. 2, p. 199, doi. 10.1002/path.4287
- By:
- Publication type:
- Article
Epistatic interactions and drug response.
- Published in:
- Journal of Pathology, 2014, v. 232, n. 2, p. 255, doi. 10.1002/path.4265
- By:
- Publication type:
- Article
Pathology in drug discovery and development.
- Published in:
- Journal of Pathology, 2014, v. 232, n. 2, p. 99, doi. 10.1002/path.4290
- By:
- Publication type:
- Article
Pathology is a necessary and informative tool in oncology clinical trials.
- Published in:
- Journal of Pathology, 2014, v. 232, n. 2, p. 185, doi. 10.1002/path.4261
- By:
- Publication type:
- Article
Molecular pathology and prostate cancer therapeutics: from biology to bedside.
- Published in:
- Journal of Pathology, 2014, v. 232, n. 2, p. 178, doi. 10.1002/path.4272
- By:
- Publication type:
- Article
The evolving genomic classification of lung cancer.
- Published in:
- Journal of Pathology, 2014, v. 232, n. 2, p. 121, doi. 10.1002/path.4275
- By:
- Publication type:
- Article
Biomarkers of drugs targeting HER-family signalling in cancer.
- Published in:
- Journal of Pathology, 2014, v. 232, n. 2, p. 219, doi. 10.1002/path.4269
- By:
- Publication type:
- Article
Using the molecular classification of glioblastoma to inform personalized treatment.
- Published in:
- Journal of Pathology, 2014, v. 232, n. 2, p. 165, doi. 10.1002/path.4282
- By:
- Publication type:
- Article
New drug targets in metastatic melanoma.
- Published in:
- Journal of Pathology, 2014, v. 232, n. 2, p. 134, doi. 10.1002/path.4259
- By:
- Publication type:
- Article
Developing biomarkers to predict benefit from HGF/ MET pathway inhibitors.
- Published in:
- Journal of Pathology, 2014, v. 232, n. 2, p. 210, doi. 10.1002/path.4268
- By:
- Publication type:
- Article
Implications of intratumour heterogeneity for treatment stratification.
- Published in:
- Journal of Pathology, 2014, v. 232, n. 2, p. 264, doi. 10.1002/path.4270
- By:
- Publication type:
- Article
Mouse tumour models to guide drug development and identify resistance mechanisms.
- Published in:
- Journal of Pathology, 2014, v. 232, n. 2, p. 103, doi. 10.1002/path.4285
- By:
- Publication type:
- Article
Somatic alterations as the basis for resistance to targeted therapies.
- Published in:
- Journal of Pathology, 2014, v. 232, n. 2, p. 244, doi. 10.1002/path.4278
- By:
- Publication type:
- Article
Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes.
- Published in:
- Journal of Pathology, 2014, v. 232, n. 2, p. 142, doi. 10.1002/path.4280
- By:
- Publication type:
- Article
A matrix approach to guide IHC-based tissue biomarker development in oncology drug discovery.
- Published in:
- Journal of Pathology, 2014, v. 232, n. 2, p. 190, doi. 10.1002/path.4262
- By:
- Publication type:
- Article
The impact of germline mutations on targeted therapy.
- Published in:
- Journal of Pathology, 2014, v. 232, n. 2, p. 230, doi. 10.1002/path.4273
- By:
- Publication type:
- Article
Mechanisms of age-related macular degeneration and therapeutic opportunities.
- Published in:
- Journal of Pathology, 2014, v. 232, n. 2, p. 151, doi. 10.1002/path.4266
- By:
- Publication type:
- Article
Dendritic cells in IBD pathogenesis: an area of therapeutic opportunity?
- Published in:
- Journal of Pathology, 2014, v. 232, n. 2, p. 112, doi. 10.1002/path.4277
- By:
- Publication type:
- Article